UPDATE: On 29 July, NICE published their final guidance not to recommend Enhertu for use on the NHS.
We will not be walking away and will do everything we can to get this decision reversed. You can still sign our petition to show NICE, NHS England, and the drug companies that Enhertu needs to be made available on the NHS.
We’re facing an emergency, and we urgently need your help.
Enhertu, a life-extending drug for certain women with incurable HER2-low secondary breast cancer, has been rejected for use on the NHS in England.
This means thousands of women will be denied access to a drug that could’ve given them the hope of more time to live.
But you can help us change this.
Join our call on NICE, NHS England and the drug companies Daiichi Sankyo and AstraZeneca, to do everything possible to find a solution that makes Enhertu available on the NHS.
Time is against us. We need to act now. Please sign and share our petition. Help give these women back their hope.